Amarin Reports Q3 Net Revenue of $49.7 Million and Operating Loss of $11.1 Million

Reuters
2025/10/29
Amarin Reports Q3 Net Revenue of $49.7 Million and Operating Loss of $11.1 Million

Amarin Corporation plc reported its financial results for the third quarter of 2025. Total net revenue for Q3 2025 was $49.7 million, an increase of 17% compared to $42.3 million in Q3 2024. Product revenue, net rose 16% to $48.6 million from $41.9 million in the same quarter last year, with U.S. product revenue increasing by 34% to $40.9 million. European product revenue decreased by 5% to $4.1 million, while Rest-of-World product revenue declined by 48% to $3.6 million. Licensing and royalties revenue was $1.1 million in Q3 2025, up from $0.4 million in Q3 2024. Operating expenses decreased by 20% to $33.3 million from $41.4 million in Q3 2024. Operating loss for the quarter was $11.1 million, down from $25.2 million in the previous year. Net loss was $7.7 million, compared to $25.1 million in Q3 2024. The company reported cash of $286.6 million at the end of the quarter. During the period, Amarin completed its transition to a fully partnered commercialization model across all international markets, with a strategy now covering close to 100 countries. The company reported initial operating margin improvements following corporate rightsizing and continued cost discipline, and reaffirmed its target of achieving sustainable positive free cash flow in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amarin Corporation plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9563999-en) on October 29, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10